• On 22 February 2021, the Food and Drug Administration (FDA) issued authorization granting IP BIOTECH, INC. the emergency use approval of SARS-CoV-2 Vaccine (Vero Cell), Inactivated [Coronavac].

Product Information
English

• Information on the safety of SARS-CoV-2 Vaccine (Vero Cell), Inactivated [Coronavac] is discussed in their comprehensive Risk Management Plan.
• For more information on reporting side effects, click here.